Moderna announced Thursday that it reached a patent license agreement with the U.S. government over the experimental COVID-19 shot. During an earnings call, CFO Jamey Mock said Moderna “entered into a nonexclusive patent license agreement with the National Institute of Allergy and Infectious Diseases, an institute or center of the NIH, to license certain patent … Continue reading Moderna Announces COVID-19 Jab Patent License Agreement With U.S. Government